Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23995713 | 1.00 | TSHR (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL23345228 | 1.00 | TSHR (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL23345001 | 0.84 | TSHR (0.30) | TSHR | |
| SCHEMBL26053264 | 0.74 | TSHR (0.34) | TSHRSMN1; SMN2 | |
| SCHEMBL26806863 | 0.74 | TSHR (0.34) | TSHRSMN1; SMN2 | |
| SCHEMBL25708713 | 0.74 | TSHR (0.34) | TSHRSMN1; SMN2 | |
| SCHEMBL23345359 | 0.74 | TSHR (0.34) | TSHRSMN1; SMN2 | |
| SCHEMBL23995714 | 0.71 | TSHR (0.32) | TSHRSMN1; SMN2 | |
| SCHEMBL23345249 | 0.71 | MMP2 (0.30) | — | |
| SCHEMBL23344765 | 0.71 | SMN1; SMN2 (0.41) | SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11168102-B1 | Bicyclic heteroaryl compounds and uses thereof | Revolution Medicines, Inc. (US) | 2021-11-09 | — | — | US | disclosed |
| US-20210139517-A1 | BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF | Revolution Medicines, Inc. | 2021-05-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11168102-B1 | Bicyclic heteroaryl compounds and uses thereof | SOS1, SOST, SOS2 | TSHR 2547/4885SMN1; SMN2 375/4885 |
| US-20210139517-A1 | BICYCLIC HETEROARYL COMPOUNDS AND USES THEREOF | SOST, SOS1, SOS2 | TSHR 2669/4885SMN1; SMN2 432/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.